A Breath of Hope Lung Foundation

A single grant of $150,000 will be awarded in support of a clinical investigator working in the field of lung cancer. Proposals should address major questions that address common mutated lung cancers. Topic areas include but are not limited to strategies to overcome resistance to immunotherapy in EGFR mutated lung cancer, predictive and prognostic markers to identify responders and non-responders, and approaches to overcome acquired resistance to targeted therapies; novel approaches to treating CNS mets in mutation-driven NSCLC; understanding mechanisms of resistance to immunotherapy in EGFR mutated lung cancer; improving prognostic value and predictive value for genetic heterogeneity across multiple mutation-positive NSCLC patients; and identifying disease-causing variants in oncogenes for NSCLC patients that may benefit with targeted therapies.

Eligible applicants must hold a doctoral degree (MD, PhD, DO, DrPH, or equivalent) and must be employed by a U.S. research institution (proof of Visa required).

Letters of Inquiry are due by December 15, 2021. Selected applicants will be invited to submit a full proposal by January 17, 2022.